Jun Ohwada

698 total citations
16 papers, 533 citations indexed

About

Jun Ohwada is a scholar working on Organic Chemistry, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Jun Ohwada has authored 16 papers receiving a total of 533 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Organic Chemistry, 9 papers in Molecular Biology and 3 papers in Infectious Diseases. Recurrent topics in Jun Ohwada's work include PI3K/AKT/mTOR signaling in cancer (5 papers), Synthesis and Biological Evaluation (4 papers) and Cancer therapeutics and mechanisms (3 papers). Jun Ohwada is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (5 papers), Synthesis and Biological Evaluation (4 papers) and Cancer therapeutics and mechanisms (3 papers). Jun Ohwada collaborates with scholars based in Japan, United States and Switzerland. Jun Ohwada's co-authors include Nobuo Shimma, Hatsuo Kawada, Nobuhiro Oikawa, Masao Tsukazaki, Hiroshi Sakamoto, Takamitsu Kobayashi, Takuo Tsukuda, Toshikazu Yamazaki, Kohsuke Asoh and Kenji Takanashi and has published in prestigious journals such as Clinical Cancer Research, Journal of Medicinal Chemistry and Bioorganic & Medicinal Chemistry.

In The Last Decade

Jun Ohwada

16 papers receiving 505 citations

Peers

Jun Ohwada

ONCOL

PRM

Somsundaram Chettiar United States

Kiyoaki Sakata United States

Stefan Buck Germany

Andrii Monastyrskyi United States

Eva Řezníčková Czechia

Diana C. West United States

Matthijs J. van Haren Netherlands

Silpa Narayanan United States

Franz A. Schmid United States

Tomáš Gucký Czechia

Somsundaram Chettiar United States

Jun Ohwada

283 ×0.9

161 ×0.9

ONCOL

61 ×0.4

PRM

124 ×0.9

66 ×0.8

Citations per year, relative to Jun Ohwada Jun Ohwada (= 1×) peers Somsundaram Chettiar

Countries citing papers authored by Jun Ohwada

Since Specialization

Citations

This map shows the geographic impact of Jun Ohwada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Ohwada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Ohwada more than expected).

Fields of papers citing papers by Jun Ohwada

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jun Ohwada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Ohwada. The network helps show where Jun Ohwada may publish in the future.

Co-authorship network of co-authors of Jun Ohwada

This figure shows the co-authorship network connecting the top 25 collaborators of Jun Ohwada. A scholar is included among the top collaborators of Jun Ohwada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jun Ohwada. Jun Ohwada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Kawada, Hatsuo, Hirosato Ebiike, Masao Tsukazaki, et al.. (2016). Optimization of the phenylurea moiety in a phosphoinositide 3-kinase (PI3K) inhibitor to improve water solubility and the PK profile by introducing a solubilizing group and ortho substituents. Bioorganic & Medicinal Chemistry. 24(13). 2897–2906. 6 indexed citations

Kawada, Hatsuo, Hirosato Ebiike, Masao Tsukazaki, et al.. (2015). Modification of a dihydropyrrolopyrimidine phosphoinositide 3-kinase (PI3K) inhibitor to improve oral bioavailability. Bioorganic & Medicinal Chemistry. 23(24). 7650–7660. 9 indexed citations

Chiba, Takashi, Jun Ohwada, Hiroshi Sakamoto, et al.. (2012). Design and evaluation of azaindole-substituted N-hydroxypyridones as glyoxalase I inhibitors. Bioorganic & Medicinal Chemistry Letters. 22(24). 7486–7489. 25 indexed citations

Kawada, Hatsuo, Hirosato Ebiike, Masao Tsukazaki, et al.. (2012). Lead optimization of a dihydropyrrolopyrimidine inhibitor against phosphoinositide 3-kinase (PI3K) to improve the phenol glucuronic acid conjugation. Bioorganic & Medicinal Chemistry Letters. 23(3). 673–678. 13 indexed citations

Tanaka, Hiroshi, Miyuki Yoshida, Hiromi Tanimura, et al.. (2011). The Selective Class I PI3K Inhibitor CH5132799 Targets Human Cancers Harboring Oncogenic PIK3CA Mutations. Clinical Cancer Research. 17(10). 3272–3281. 79 indexed citations

Ohwada, Jun, Hirosato Ebiike, Hatsuo Kawada, et al.. (2011). Discovery and biological activity of a novel class I PI3K inhibitor, CH5132799. Bioorganic & Medicinal Chemistry Letters. 21(6). 1767–1772. 56 indexed citations

Asoh, Kohsuke, Noriyuki Furuichi, Toshiya Ito, et al.. (2011). Design and synthesis of a highly selective, orally active and potent anaplastic lymphoma kinase inhibitor (CH5424802). Bioorganic & Medicinal Chemistry. 20(3). 1271–1280. 134 indexed citations

Kobayashi, Takamitsu, Kohsuke Asoh, Noriyuki Furuichi, et al.. (2011). 9-Substituted 6,6-Dimethyl-11-oxo-6,11-dihydro-5H-benzo[b]carbazoles as Highly Selective and Potent Anaplastic Lymphoma Kinase Inhibitors. Journal of Medicinal Chemistry. 54(18). 6286–6294. 61 indexed citations

Yamazaki, Toshikazu, Toshihiko Fujii, Jun Ohwada, et al.. (2010). In vitro activity of isavuconazole against 140 reference fungal strains and 165 clinically isolated yeasts from Japan. International Journal of Antimicrobial Agents. 36(4). 324–331. 37 indexed citations

10.

Endo, Mika, Masanori Miwa, Masako Ura, et al.. (2009). A water soluble prodrug of a novel camptothecin analog is efficacious against breast cancer resistance protein-expressing tumor xenografts. Cancer Chemotherapy and Pharmacology. 65(2). 363–371. 13 indexed citations

11.

Ohwada, Jun, Masao Tsukazaki, Tadakatsu Hayase, et al.. (2003). Design, synthesis and antifungal activity of a novel water soluble prodrug of antifungal triazole. Bioorganic & Medicinal Chemistry Letters. 13(2). 191–196. 63 indexed citations

12.

Ohwada, Jun, et al.. (2002). Synthesis of novel water soluble benzylazolium prodrugs of lipophilic azole antifungals. Bioorganic & Medicinal Chemistry Letters. 12(19). 2775–2780. 10 indexed citations

13.

Fujii, Toshihiko, et al.. (1995). Design of an Antifungal Methionine Inhibitor Not Antagonized by Methionine.. Biological and Pharmaceutical Bulletin. 18(9). 1267–1271. 6 indexed citations

14.

Ohwada, Jun, et al.. (1995). ChemInform Abstract: Synthesis and Structure‐Activity Relationships of a Novel Antifungal Agent, Azoxybacilin.. ChemInform. 26(13). 1 indexed citations

15.

Ohwada, Jun, et al.. (1994). Synthesis and Structure Activity Relationships of a Novel Antifungal Agent, Azoxybacilin.. Chemical and Pharmaceutical Bulletin. 42(8). 1703–1705. 10 indexed citations

16.

Ohwada, Jun, et al.. (1990). Acyliminium Cyclization of Several Chiral N-Alkenylsuccinimide Derivatives. Bulletin of the Chemical Society of Japan. 63(1). 287–289. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact